Insoluble bismuth (subsalicylate) should be revived for treatment of LE in general and SCLE in particular.
Arnold
H L
HL
D001729:Bismuth; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D009942:Organometallic Compounds / Q000627:therapeutic use*; D012459:Salicylates / Q000627:therapeutic use*; D013587:Syphilis / Q000188:drug therapy
D009942:Organometallic Compounds; D012459:Salicylates; C015715:bismuth subsalicylate; D001729:Bismuth